[TAVI and coronary revascularization].
Combaret N, Bouchant M, Motreff P, Souteyrand G.
Ann Cardiol Angeiol (Paris). 2019 Dec;68(6):423-428. doi: 10.1016/j.ancard.2019.09.019. Epub 2019 Oct 21.
Bivalirudin: pharmacology and clinical applications.
Shammas NW.
Cardiovasc Drug Rev. 2005 Winter;23(4):345-60. doi: 10.1111/j.1527-3466.2005.tb00177.x.
Bleeding complications with PCI.
Satler LF.
Catheter Cardiovasc Interv. 2005 Mar;64(3):373-4. doi: 10.1002/ccd.20303.
Lost and found: Coronary stent retrieval and review of literature.
Malik SA, Brilakis ES, Pompili V, Chatzizisis YS.
Catheter Cardiovasc Interv. 2018 Jul;92(1):50-53. doi: 10.1002/ccd.27464. Epub 2018 Jan 4.
The decline in PCI complication rate: 2003-2006 versus 1999-2002.
Stathopoulos I, Jimenez M, Panagopoulos G, Kwak EJ, Losquadro M, Cohen H, Iyer S, Ruiz C, Roubin G, Garratt K.
Hellenic J Cardiol. 2009 Sep-Oct;50(5):379-87.
Restenosis after PCI. Part 1: pathophysiology and risk factors.
Jukema JW, Verschuren JJ, Ahmed TA, Quax PH.
Nat Rev Cardiol. 2011 Sep 13;9(1):53-62. doi: 10.1038/nrcardio.2011.132.
Evaluation of stents and grafts.
de Graaf FR, Schuijf JD.
EuroIntervention. 2010 May;6 Suppl G:G48-56.
Low-molecular-weight heparin vs. unfractionated heparin in percutaneous coronary intervention: a combined analysis.
Borentain M, Montalescot G, Bouzamondo A, Choussat R, Hulot JS, Lechat P.
Catheter Cardiovasc Interv. 2005 Jun;65(2):212-21. doi: 10.1002/ccd.20352.
Complex robotic-enhanced percutaneous coronary intervention.
Kapur V, Smilowitz NR, Weisz G.
Catheter Cardiovasc Interv. 2014 May 1;83(6):915-21. doi: 10.1002/ccd.25271. Epub 2014 Apr 4.
Gender differences in the outcome of cardiac interventions.
Tillmanns H, Waas W, Voss R, Grempels E, Hölschermann H, Haberbosch W, Waldecker B.
Herz. 2005 Aug;30(5):375-89. doi: 10.1007/s00059-005-2716-3.
